Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer

Julie K. Schwarz, Sushil Beriwal, Jacqueline Esthappan, Beth Erickson, Colleen Feltmate, Anthony Fyles, David Gaffney, Ellen Jones, Ann Klopp, William Small, Bruce Thomadsen, Catheryn Yashar, Akila Viswanathan

Research output: Contribution to journalArticle

Abstract

Purpose: The purpose of this consensus statement from the American Brachytherapy Society (ABS) is to summarize recent advances and to generate general guidelines for the management of medically inoperable endometrial cancer patients with radiation therapy. Methods: Recent advances in the literature were summarized and reviewed by a panel of experts. Panel members participated in a series of conference calls and were surveyed to determine their current practices and patterns. This document was reviewed and approved by the full panel, the ABS Board of Directors and the ACR Commission on Radiation Oncology. Results: A transition from two-dimensional (2D) to three-dimensional (3D) treatment planning for the definitive treatment of medically inoperable endometrial cancer is described. Magnetic resonance (MR) imaging can be used to define the gross tumor volume (GTV), clinical target volume (CTV), and the organs at risk (OARs). Brachytherapy alone can be used for medically inoperable endometrial cancer patients with clinical Stage I cancer with no lymph node involvement and no evidence of deep invasion of the myometrium on MR imaging. In the absence of MR imaging, a combined approach using external beam and brachytherapy may be considered. Conclusions: Recent advances support the use of MR imaging and 3D planning for brachytherapy treatment for medically inoperable endometrial cancer.

Original languageEnglish (US)
Pages (from-to)587-599
Number of pages13
JournalBrachytherapy
Volume14
Issue number5
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Brachytherapy
Endometrial Neoplasms
Magnetic Resonance Imaging
Organs at Risk
Radiation Oncology
Myometrium
Therapeutics
Tumor Burden
Radiotherapy
Lymph Nodes
Guidelines
Neoplasms

Keywords

  • Brachytherapy
  • Endometrial carcinoma
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. / Schwarz, Julie K.; Beriwal, Sushil; Esthappan, Jacqueline; Erickson, Beth; Feltmate, Colleen; Fyles, Anthony; Gaffney, David; Jones, Ellen; Klopp, Ann; Small, William; Thomadsen, Bruce; Yashar, Catheryn; Viswanathan, Akila.

In: Brachytherapy, Vol. 14, No. 5, 01.09.2015, p. 587-599.

Research output: Contribution to journalArticle

Schwarz, JK, Beriwal, S, Esthappan, J, Erickson, B, Feltmate, C, Fyles, A, Gaffney, D, Jones, E, Klopp, A, Small, W, Thomadsen, B, Yashar, C & Viswanathan, A 2015, 'Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer', Brachytherapy, vol. 14, no. 5, pp. 587-599. https://doi.org/10.1016/j.brachy.2015.06.002
Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A et al. Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy. 2015 Sep 1;14(5):587-599. https://doi.org/10.1016/j.brachy.2015.06.002
Schwarz, Julie K. ; Beriwal, Sushil ; Esthappan, Jacqueline ; Erickson, Beth ; Feltmate, Colleen ; Fyles, Anthony ; Gaffney, David ; Jones, Ellen ; Klopp, Ann ; Small, William ; Thomadsen, Bruce ; Yashar, Catheryn ; Viswanathan, Akila. / Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. In: Brachytherapy. 2015 ; Vol. 14, No. 5. pp. 587-599.
@article{095a9a7e40d74187b8a33aa972dfa76c,
title = "Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer",
abstract = "Purpose: The purpose of this consensus statement from the American Brachytherapy Society (ABS) is to summarize recent advances and to generate general guidelines for the management of medically inoperable endometrial cancer patients with radiation therapy. Methods: Recent advances in the literature were summarized and reviewed by a panel of experts. Panel members participated in a series of conference calls and were surveyed to determine their current practices and patterns. This document was reviewed and approved by the full panel, the ABS Board of Directors and the ACR Commission on Radiation Oncology. Results: A transition from two-dimensional (2D) to three-dimensional (3D) treatment planning for the definitive treatment of medically inoperable endometrial cancer is described. Magnetic resonance (MR) imaging can be used to define the gross tumor volume (GTV), clinical target volume (CTV), and the organs at risk (OARs). Brachytherapy alone can be used for medically inoperable endometrial cancer patients with clinical Stage I cancer with no lymph node involvement and no evidence of deep invasion of the myometrium on MR imaging. In the absence of MR imaging, a combined approach using external beam and brachytherapy may be considered. Conclusions: Recent advances support the use of MR imaging and 3D planning for brachytherapy treatment for medically inoperable endometrial cancer.",
keywords = "Brachytherapy, Endometrial carcinoma, Magnetic resonance imaging",
author = "Schwarz, {Julie K.} and Sushil Beriwal and Jacqueline Esthappan and Beth Erickson and Colleen Feltmate and Anthony Fyles and David Gaffney and Ellen Jones and Ann Klopp and William Small and Bruce Thomadsen and Catheryn Yashar and Akila Viswanathan",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.brachy.2015.06.002",
language = "English (US)",
volume = "14",
pages = "587--599",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer

AU - Schwarz, Julie K.

AU - Beriwal, Sushil

AU - Esthappan, Jacqueline

AU - Erickson, Beth

AU - Feltmate, Colleen

AU - Fyles, Anthony

AU - Gaffney, David

AU - Jones, Ellen

AU - Klopp, Ann

AU - Small, William

AU - Thomadsen, Bruce

AU - Yashar, Catheryn

AU - Viswanathan, Akila

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Purpose: The purpose of this consensus statement from the American Brachytherapy Society (ABS) is to summarize recent advances and to generate general guidelines for the management of medically inoperable endometrial cancer patients with radiation therapy. Methods: Recent advances in the literature were summarized and reviewed by a panel of experts. Panel members participated in a series of conference calls and were surveyed to determine their current practices and patterns. This document was reviewed and approved by the full panel, the ABS Board of Directors and the ACR Commission on Radiation Oncology. Results: A transition from two-dimensional (2D) to three-dimensional (3D) treatment planning for the definitive treatment of medically inoperable endometrial cancer is described. Magnetic resonance (MR) imaging can be used to define the gross tumor volume (GTV), clinical target volume (CTV), and the organs at risk (OARs). Brachytherapy alone can be used for medically inoperable endometrial cancer patients with clinical Stage I cancer with no lymph node involvement and no evidence of deep invasion of the myometrium on MR imaging. In the absence of MR imaging, a combined approach using external beam and brachytherapy may be considered. Conclusions: Recent advances support the use of MR imaging and 3D planning for brachytherapy treatment for medically inoperable endometrial cancer.

AB - Purpose: The purpose of this consensus statement from the American Brachytherapy Society (ABS) is to summarize recent advances and to generate general guidelines for the management of medically inoperable endometrial cancer patients with radiation therapy. Methods: Recent advances in the literature were summarized and reviewed by a panel of experts. Panel members participated in a series of conference calls and were surveyed to determine their current practices and patterns. This document was reviewed and approved by the full panel, the ABS Board of Directors and the ACR Commission on Radiation Oncology. Results: A transition from two-dimensional (2D) to three-dimensional (3D) treatment planning for the definitive treatment of medically inoperable endometrial cancer is described. Magnetic resonance (MR) imaging can be used to define the gross tumor volume (GTV), clinical target volume (CTV), and the organs at risk (OARs). Brachytherapy alone can be used for medically inoperable endometrial cancer patients with clinical Stage I cancer with no lymph node involvement and no evidence of deep invasion of the myometrium on MR imaging. In the absence of MR imaging, a combined approach using external beam and brachytherapy may be considered. Conclusions: Recent advances support the use of MR imaging and 3D planning for brachytherapy treatment for medically inoperable endometrial cancer.

KW - Brachytherapy

KW - Endometrial carcinoma

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=84940028442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940028442&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2015.06.002

DO - 10.1016/j.brachy.2015.06.002

M3 - Article

C2 - 26186975

AN - SCOPUS:84940028442

VL - 14

SP - 587

EP - 599

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 5

ER -